Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights a significant net loss, increased R&D spending, and vague timelines for key technology adoptions, which could lead to investor concerns. Despite securing government contracts and partnerships, the lack of immediate revenue impact and unclear guidance adjustments contribute to a negative sentiment.
Revenue $1.2 million for the fiscal third quarter, compared to $1.3 million in the third quarter of last year and $1.3 million in the second quarter of fiscal 2026. The year-over-year decrease is attributed to fluctuations in government R&D contracts.
GAAP Net Loss $1.8 million, or $0.10 per basic and diluted share, compared to net income of $1.5 million, or $0.12 per share in the prior year period. The year-over-year change is primarily due to a one-time $2.3 million gain in the fair value of derivative liabilities recorded in the third quarter of 2025.
Non-GAAP Net Loss $701,000, or $0.04 per share, compared to breakeven in the third quarter last year. The increase in loss is due to higher employee-related costs and R&D spending.
Adjusted EBITDA Loss $911,000 compared to a gain of $109,000 in the same period last year. The loss reflects increased spending on new hires and R&D investments.
Cash and Cash Equivalents $37.8 million at the end of the quarter, with no long-term debt. Cash decreased by $792,000 from the previous quarter due to increased spending on new hires and R&D investments.
Government Contracts Secured 6 contracts totaling well over $5 million in value, contributing to non-dilutive funding for R&D and strategic partnerships.
High-speed InGaAs photodiodes: Aeluma is developing high-speed InGaAs photodiodes on non-indium phosphide substrates to address supply constraints and cost issues. These photodiodes are being designed for AI data centers and defense applications.
MOCVD quantum dot lasers: Aeluma is the first company to offer MOCVD quantum dot lasers, which provide high-power handling, scalability, and better reliability for AI data centers and other applications.
SWIR sensors for mobile: Aeluma is working on shortwave infrared (SWIR) sensors for mobile and consumer electronics, aiming to improve eye safety and imaging performance while reducing costs through scalable manufacturing.
AI datacom and data centers: Aeluma is targeting the AI datacom market, which is experiencing massive growth due to increased data center investments. The company is positioning its photonics technology to address supply gaps and future growth opportunities.
Mobile and consumer electronics: Aeluma is engaging with OEMs and suppliers to develop SWIR sensors for smartphones, a market with massive scale potential.
Defense and aerospace: Aeluma has secured over $5 million in government contracts to develop dual-use technologies applicable to both defense and commercial markets.
Strategic partnerships: Aeluma has partnered with Tower Semiconductor and Sumitomo Chemical Advanced Technologies to scale production and integrate its technology into silicon-based systems.
Team expansion: Aeluma has added key personnel, including a VP of Materials Operations and a VP of Strategic Partnerships, to enhance operations and commercialization efforts.
Non-indium phosphide substrates: Aeluma is focusing on non-indium phosphide substrates to overcome supply chain constraints and reduce costs, positioning itself as a scalable solution provider in the photonics industry.
Capital-light model: The company is leveraging partnerships and licensing opportunities to execute a capital-light model for high-volume applications.
Supply Chain Constraints: The supply chain for indium phosphide substrates is severely constrained, with suppliers sold out for years and limited capacity increases expected in the near term. Geopolitical uncertainties further exacerbate the issue.
Scaling Challenges: Adding fab capacity for indium phosphide substrates may take several years, and transitioning to 6-inch substrates is unlikely to meet market demand. This creates a bottleneck for scaling production.
High-Power Laser Reliability: High-power lasers for transceivers are failing at high power and high temperatures, creating a bottleneck in commercial applications. Customers demand more power and better reliability.
Government Contract Delays: Delays in the execution of government contracts and subsequent program starts have impacted revenue guidance and created uncertainty in quarter-to-quarter and year-to-year revenue.
R&D and Operational Costs: Increased spending on new hires and R&D has led to higher operational costs, contributing to financial losses.
Revenue Uncertainty: Revenue guidance was narrowed due to delays in government contracts, highlighting the uncertainty associated with relying on such funding sources.
AI Infrastructure and Data Centers: The company anticipates a significant increase in data center CapEx investments, with projections of $700 billion in 2026 and surpassing $1 trillion by 2029. Optical networking is expected to account for approximately 15% of this investment. Aeluma's photonics technology is positioned to address current supply gaps and long-term growth opportunities in this market.
Photonics Product Development: Aeluma is focusing on developing high-speed InGaAs photodiodes and MOCVD quantum dot lasers to address supply constraints and performance requirements in AI data centers. These technologies are expected to overcome current bottlenecks and enable scalability and reliability.
Mobile and Consumer Electronics: The company is targeting the adoption of shortwave infrared (SWIR) sensors in smartphones, which are expected to improve eye safety, achieve high-resolution imaging, and preserve screen real estate. Aeluma's InGaAs photodiode arrays on non-indium phosphide substrates are being optimized for performance and scalability. Qualification and production are expected to require a multi-year effort.
Defense and Aerospace: Aeluma's technology is dual-use, applicable to both defense and commercial markets. The company has secured six development contracts totaling over $5 million in value, with a focus on advancing quantum dot lasers and quantum non-linear materials. These contracts are expected to transition to later-stage programs benefiting both sectors.
Supply Chain and Scaling: Aeluma is working with various supply chain partners to scale production and meet demand. The company is leveraging non-indium phosphide substrates to overcome supply chain constraints and reduce costs. Partnerships with foundries like Tower Semiconductor are key to enabling integration on silicon for next-generation applications.
Revenue Guidance: The company updated its full-year revenue guidance to $4.2 million to $4.6 million, narrowed from the previous range of $4 million to $6 million. This adjustment is due to delays in government contract execution and program starts. Future government bids will focus on later-stage development and transition opportunities.
The selected topic was not discussed during the call.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.